{"altmetric_id":4689619,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Viralytics"],"first_seen_on":"2015-10-28T13:22:24+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1449212557,"links":["http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00636558"],"nct_id":"NCT00636558","pubdate":"2008-03-07T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers","type":"clinical_trial_study_record"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":6647401,"mean":6.157074757346,"rank":1547715,"this_scored_higher_than_pct":67,"this_scored_higher_than":4459945,"rank_type":"exact","sample_size":6647401,"percentile":67},"similar_age_3m":{"total_number_of_other_articles":235782,"mean":9.4224584847803,"rank":67590,"this_scored_higher_than_pct":70,"this_scored_higher_than":165065,"rank_type":"exact","sample_size":235782,"percentile":70},"this_journal":{"total_number_of_other_articles":16746,"mean":9.2505231412362,"rank":5490,"this_scored_higher_than_pct":65,"this_scored_higher_than":10922,"rank_type":"exact","sample_size":16746,"percentile":65},"similar_age_this_journal_3m":{"total_number_of_other_articles":869,"mean":13.255532258065,"rank":286,"this_scored_higher_than_pct":66,"this_scored_higher_than":581,"rank_type":"exact","sample_size":869,"percentile":66}}},"demographics":[],"counts":{"total":{"posts_count":2},"wikipedia":{"unique_users_count":2,"unique_users":["en:38152513","en:48722637"],"posts_count":2}},"posts":{"wikipedia":[{"title":"Cavatak","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=531735761#altmetric_citation_7","license":"public","citation_ids":[4689619],"posted_on":"2013-01-07T04:51:22+00:00","summary":"Cavatak is the trade name for a preparation of wild-type Coxsackievirus A21 (CVA21) developed by the Australian biotechnology company Viralytics Ltd.","page_url":"http:\/\/en.wikipedia.org\/?curid=38152513","wiki_lang":"en","author":{"name":"Goughau","url":"http:\/\/en.wikipedia.org\/wiki\/User:Goughau"}},{"title":"Viralytics","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=693695920#altmetric_citation_1a85d9db-5fee-4572-bbd5-93858cc687d7","license":"public","citation_ids":[4689619],"posted_on":"2015-12-04T07:02:37+00:00","summary":"Viralytics Ltd is a Australian biotechnology company working in the field of oncolytic viruses, that is, viruses that preferentially infect and kills cancer cells.","page_url":"http:\/\/en.wikipedia.org\/?curid=48722637","wiki_lang":"en","author":{"name":"OzBioMan","url":"http:\/\/en.wikipedia.org\/wiki\/User:OzBioMan"}}]}}